January 20, 2022 | cervical cancer, cervical cancer awareness month, clinical trials, diveristy, patient recruitment
In this first 2022 blog, the Innovative Trials’ Equality & Diversity committee will be looking at raising awareness around Cervical Cancer
Cervical cancer remains  a threatening disease for many women, in fact every year in the UK, as many as 3,200 women are diagnosed with cervical cancer, with about 2 women dying every day.
Read the full blog here
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to…
We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient…
UK-based patient recruitment company announces its annual charity partnership in support of multiple sclerosis
Innovative Trials and Parexel invite you to attend the live webinar
The patient recruitment organisation has been shortlisted in the Inspiring Hertfordshire awards
Kate Shaw, Founder & CEO of the leading patient recruitment organisation based in Letchworth (UK), on the current Russia-Ukraine situation.
A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many studies find diverse patient recruitment…
Phase IIa Moderate to Severe Hidradenitis Suppurativa Case Study
In the latest blog post, Innovative Trials’ Equality & Diversity committee focuses on eating disorders
Innovative Trials, Pfizer and Parexel invite you to attend the live webinar
